Stork Club helps employers offer fertility and parental benefits to its employees. It covers a range of fertility services including diagnostics, egg freezing, in vitro diagnostics, and surrogacy. The company looks to reduce the fertility care related expenses borne by employers, and claims that enterprises with a few thousand employees can save up to USD 3 million per annum. Using Stork Club, employees can choose from doctors, clinics, and labs in the network, and know the exact out-of-pocket cost before making decisions.
Its customers include Ropes & Gray, Crescent Capital, Corgan, and Fors Marsh Group, among others. The company claims that its revenue grew 5x YoY in 2020, and that its medical network grew to over 250 locations in the US, including CCRM, Boston IVF, Vios Fertility, and Coopergenomics, among others. Moreover, it also launched a cohesive fertility pharmacy experience for its members, during the year.
Stork Club raised USD 30 million in Series A funding, led by General Catalyst in June 2021, and intends to use the funds to meet growing demand and expand its line of family-related services.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.